Inventor
HE XIAO-SHU
US35 patents
⚠️ This page may combine multiple inventors who share the name “HE XIAO-SHU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEUROGEN CORP
22 patentsUS6723743B1Apr 20, 2004
High affinity small molecule C5a receptor modulators
NEUROGEN CORP32 citations92
US6432958B1Aug 13, 2002
2-piperazinoalkylaminobenzoazole derivatives: dopamine receptor subtype specific ligands
NEUROGEN CORP33 citations92
US6284759B1Sep 4, 2001
2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
NEUROGEN CORP40 citations92
US6245768B1Jun 12, 2001
1-(N′-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands
NEUROGEN CORP31 citations92
US6288230B1Sep 11, 2001
2-(2, 3-dihydrobenzofuran-5-yl)-4-aminomethylimidazoles: dopamine receptor subtype specific ligands
NEUROGEN CORP11 citations74
US6100255AAug 8, 2000
3-aminoalkylamino-2H-1,4-benzoxazines and 3-aminoalkylamino-2H-1,4-benzothiazines: dopamine receptor subtype specific ligands
NEUROGEN CORP7 citations74
US6884815B1Apr 26, 2005
High affinity small molecule C5a receptor modulators
NEUROGEN CORP9 citations73
US6482844B1Nov 19, 2002
1-benzylimidazole derivatives
NEUROGEN CORP13 citations73
US6031097AFeb 29, 2000
1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands
NEUROGEN CORP5 citations73
US5744472AApr 28, 1998
1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands
NEUROGEN CORP7 citations73
US5656632AAug 12, 1997
1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; dopamine receptor subtype specific ligands
NEUROGEN CORP6 citations73
US5602168AFeb 11, 1997
1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; dopamine receptor subtype specific ligands
NEUROGEN CORP9 citations73
US6313141B1Nov 6, 2001
2-aminoalkylaminoquinolines as dopamine D4 ligands
NEUROGEN CORP2 citations63
US5972945AOct 26, 1999
2-aminoalkylaminoquinolines; dopamine receptor subtype specific ligands
NEUROGEN CORP4 citations63
US6509366B2Jan 21, 2003
Substituted imidazoles as selective modulators of Bradykinin B2 receptors
NEUROGEN CORP7 citations62
US6252077B1Jun 26, 2001
1-(N′-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands
NEUROGEN CORP1 citations62
US5932729AAug 3, 1999
1-(N'-(arylalkylaminoalkyl)) aminoisoindoles; a new class of dopamine receptor subtype specific ligands
NEUROGEN CORP3 citations62
US7271270B2Sep 18, 2007
High affinity small molecule C5a receptor modulators
NEUROGEN CORP1 citations52
US6613901B2Sep 2, 2003
2-aminoalkylaminoquinolines as dopamine D4 ligands
NEUROGEN CORP0 citations52
US6432946B1Aug 13, 2002
3-aminoalkylamino-2H-1,4-benzoxazines and 3-aminoalkylamino-2H-1,4-benzothiazines: dopamine receptor subtype specific ligands
NEUROGEN CORP0 citations52
US6441175B1Aug 27, 2002
1-(N'-arylalkylaminoalkyl)aminoisoquinolines: a new class of dopamine receptor subtype
NEUROGEN CORP0 citations51
US7241765B2Jul 10, 2007
Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
NEUROGEN CORP0 citations50
US HEALTH
10 patentsUS5679673AOct 21, 1997
Aralkyl bridged diazabicycloalkane derivatives for CNS disorders
US HEALTH74 citations96
US5171750ADec 15, 1992
Substituted phenserines as specific inhibitors of acetylcholinesterase
US HEALTH56 citations94
US5378723AJan 3, 1995
Carbamate analogs of thiaphysovenine and method for inhibiting cholinesterases
US HEALTH24 citations92
US5569447AOct 29, 1996
Stannylated 3-quinuclidinyl benzilates and methods of preparing radiohalogenated derivatives
US HEALTH17 citations76
US5958920ASep 28, 1999
Aralkyl diazabicycloalkane derivatives for CNS disorders
US HEALTH9 citations73
US5856318AJan 5, 1999
Nitrogen-containing cyclohetero cyclo-heteroaminoaryl derivatives for CNS disorders
US HEALTH2 citations62
US5679679AOct 21, 1997
Aralkyl diazabicycloalkane derivatives for CNS disorders
US HEALTH6 citations62
US5656625AAug 12, 1997
Nitrogen-containing cyclohetero cycloheteroaminoaryl derivatives for CNS disorders
US HEALTH3 citations62
US5346908ASep 13, 1994
Nitrogen-containing cyclohetero cycloheteroaminoaryl derivatives for CNS disorders
US HEALTH3 citations62
US6656930B2Dec 2, 2003
Aralkyl diazabicycloalkane derivatives for CNS disorders
US HEALTH0 citations40